DUXAP8 and colorectal carcinoma: Experiments involving DUXAP8 knockdown demonstrated its ability to impede cell proliferation, migration, and invasion in CRC cells, suggesting its potential role in modulating metastatic potential and impacting CRC development through its effects on cellular proliferation and apoptosis [17].